Scite vs AgingResearch.News
Choose Scite for
Researchers checking how a paper has been cited, in any field: whether the studies that cite it support or contrast its claims.
Choose AgingResearch.News for
People who follow aging research and want the new papers read and judged for them, and each drug's, gene's or process's evidence on one page, findings against included.
Side by side
- What it is
- AgingResearch.News A reader of aging research: feeds, stories, evidence pages and Ask
- Scite Smart Citations, “showing whether studies support or contradict a claim”1
- Coverage
- AgingResearch.News Aging research only: biology, clinical work, AI and data, and the field's trials, grants, companies and news.
- Scite 1.7B+ Smart Citations and 323M+ articles indexed2
- Findings against
- AgingResearch.News A treatment's page counts the findings that point the other way, each linked to its paper
- Scite Each citation classified as supporting or contrasting1
- Alerts
- AgingResearch.News Follow a drug, gene, author or search and get an email when a new paper lands (3 free, 25 with Plus). Plus builds For you from a sentence about your work.
- Scite Citation alerts and dashboards1
- Tools
- AgingResearch.News An MCP server for ChatGPT, Claude and other assistants (100 lookups a day with a free account), a data API and a Chrome extension.
- Scite MCP, API, a Zotero plugin and a browser extension1
- Free
- AgingResearch.News Every feed, story and page without an account. A free account adds 3 questions a day to Ask, 3 follows with email and the Monday digest.
- Scite No free plan; a 7-day trial1
- Price
- AgingResearch.News Free to read. Plus $12 a month or $99 a year; Pro, for company and pipeline intelligence, $59 a month.
- Scite $12 and $40 a month, billed yearly1
Where Scite is stronger
- It classifies how each citation uses a paper, across 1.7 billion citation statements; AgingResearch.News does not read citations that way.
- It has full-text indexing agreements with publishers.
- It has a Zotero plugin and a browser extension that badges citations.
- Its higher plans add patent, clinical trial and grant datasets, and regulatory and safety data (FAERS, MAUDE, 510(k)).
Where AgingResearch.News is different
- It reads each new aging paper as it appears and judges what the paper's own work shows about aging.
- The papers worth reading become short stories in plain words, each checked against its paper.
- A treatment's evidence is shown as structure: the species it reached, independent labs and countries, findings against, trials with no results posted, funders and company ties.
- Reading needs no account, and a free account adds Ask, follows and the Monday digest.
On AgingResearch.News now
On a typical day this past week, 4,300 new papers were read and 56 stories published, from a record of 707,854 papers.
- Blood test model may reduce Alzheimer’s brain-scan use
Study in people · Oct 20, 2026
- Cancer-promoting signals and immunity shape cell clearance in mice
Experiments in animals · Oct 20, 2026
- Face-photo predictions linked to mortality in cancer patients
Study in people · Oct 20, 2026
- Rapamycin
An evidence page: species, independent labs, findings against, trials
- Metformin
Its studies, trials and stage toward patients on one page
- Top
The day's most significant aging research, as stories
- Ask AgingResearch.News
Questions answered from the papers, every claim cited
- Trials
Clinical trials judged for what they mean for aging
- In your AI assistant
AgingResearch.News inside ChatGPT, Claude and others
Sources
Every fact about Scite above is from its own pages, read on the date given.
- 1. Scite: Pricing, read Oct 20, 2026
- 2. Scite: Coverage, read Oct 20, 2026